CLINICAL_TRIALS
research
· 2025-12-01
Clinical Trial Update: DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) [Phase 2]
Summary
A Phase 2 clinical trial evaluating DZD8586 in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma is currently recruit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dizal Pharmaceuticals | Conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING